Koliadiuk I V, Volkova M A
Vopr Onkol. 1978;24(11):87-91.
The rationale of using preoperative radiotherapy as an adjunct in the combination therapy of gastric cancer is discussed. 102 patients mostly with the process in stage III (91) were treated. The analysis made enabled the authors to reveal a significant increase of resectability in a group of patients receiving distant gammatherapy. This index was 72.2% versus generally accepted indices 55--65%. The survival in this group of patients with terms of the follow-up from 5 to 8 years made 32.3% versus 20.8% of only a 5-year survival in a group of patients treated surgically.
讨论了术前放疗作为胃癌联合治疗辅助手段的基本原理。对102例大多处于Ⅲ期(91例)病程的患者进行了治疗。分析使作者能够发现在接受远距离γ放疗的患者组中可切除性显著提高。该指标为72.2%,而普遍接受的指标为55% - 65%。该组患者随访5至8年的生存率为32.3%,而仅接受手术治疗的患者组5年生存率为20.8%。